CAS RN: 1354940-72-9
1,2,3,4-Tetrahydro-2,7-naphthyridine hydrochloride
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g, 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1354940-72-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
5g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1354940-72-9 / 1,2,3,4-tetrahydro-2,7-naphthyridine;hydrochloride
Standard CAS: 1354940-72-9
Multi CAS: No
Basic Information
copy
CAS
1354940-72-9 copy
Multi CAS
No copy
Molecular Formula
C8H11ClN2 copy
Molecular Weight
170.640000 copy
Exact Mass
170.061076 copy
SMILES
C1CNCC2=C1C=CN=C2.Cl copy
InChI
InChI=1S/C8H10N2.ClH/c1-3-9-5-8-6-10-4-2-7(1)8;/h1,3,5,10H,2,4,6H2;1H copy
InChIKey
WRARFMNQYDXJET-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.38 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
46.9 copy
TPSA
24.92 copy
LogP / Solubility
WLOGP
1.15 copy
MLOGP
1.01 copy
XLogP3
1.15 copy
Consensus LogP
1.1 copy
Log S (ESOL)
-2.03 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.79 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.72 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.95 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy